AlphaCrest Capital Management’s Nu Skin NUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-47,742
Closed -$1.59M 775
2022
Q3
$1.59M Buy
47,742
+31,352
+191% +$1.31M 0.1% 323
2022
Q2
$710K Buy
16,390
+9,373
+134% +$430K 0.03% 823
2022
Q1
$336K Buy
+7,017
New +$348K 0.02% 1073
2021
Q4
Sell
-15,554
Closed -$629K 1416
2021
Q3
$629K Buy
15,554
+4,097
+36% +$207K 0.03% 820
2021
Q2
$649K Sell
11,457
-2,575
-18% -$147K 0.03% 856
2021
Q1
$742K Buy
14,032
+2,438
+21% +$133K 0.04% 625
2020
Q4
$633K Buy
+11,594
New +$610K 0.05% 521
2020
Q3
Sell
-11,673
Closed -$446K 1163
2020
Q2
$446K Buy
+11,673
New +$375K 0.07% 432
2019
Q4
Sell
-25,716
Closed -$1.09M 1330
2019
Q3
$1.09M Buy
25,716
+8,197
+47% +$344K 0.07% 524
2019
Q2
$864K Buy
+17,519
New +$891K 0.07% 469

Other funds holding NUS

AlphaCrest Capital Management's NUS Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of Nu Skin (NUS) in Q4 2022, closing a stake of 47,742 shares — an estimated $1.59M sold.

AlphaCrest Capital Management first reported a position in NUS in Q2 2019 and held it in 10 quarters. The position peaked at $1.59M in Q3 2022. 218 funds tracked by Wall St. Rank hold NUS as of Q4 2022.

  • AlphaCrest Capital Management reported no remaining Nu Skin position as of Q4 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 47,742 Nu Skin shares in Q4 2022, an estimated $1.59M.
  • AlphaCrest Capital Management first reported a position in Nu Skin in Q2 2019 and held it in 10 quarters.
  • AlphaCrest Capital Management's Nu Skin position peaked at $1.59M in Q3 2022.
  • 218 funds tracked by Wall St. Rank held Nu Skin as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.